Aligos Therapeutics
Clinical trials sponsored by Aligos Therapeutics, explained in plain language.
-
New pill shows promise in early hepatitis b trial
Disease control CompletedThis early-stage study tested a new oral drug called ALG-000184 in 165 people, including healthy volunteers and patients with chronic hepatitis B. The main goal was to check if the drug is safe and how the body processes it. Researchers also looked at whether it can lower hepatit…
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Liver study tests COVID drug safety in 16 volunteers
Knowledge-focused CompletedThis study looked at how the experimental COVID-19 drug ALG-097558 behaves in people with moderate liver impairment compared to healthy adults. Sixteen participants took the drug twice daily, and researchers measured drug levels in the blood and monitored side effects. The goal w…
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
Kidney function may change how COVID drug works
Knowledge-focused CompletedThis study looked at how the drug ALG-097558 behaves in people with severe kidney problems compared to healthy people. It involved 12 adults who took the drug twice daily. The goal was to see if kidney function affects drug levels and safety, not to test if it treats COVID-19.
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC